References

Al-Rimawi, H.S., M.F. Jallad, Z.O. Amarin and B.R. Obeidat, 2005. Hypothalamic-pituitary-gonadal functions in adolescent females with β-thalassemia major. Int. J. Gynaecol. Obstet., 90: 44-47.
CrossRef  |  

Aldudak, B., A. Karabay Bayazit, A. Noyan, A. Ozel and A. Anarat et al., 2000. Renal function in pediatric patients with β-thalassemia major. Pediatr. Nephrol., 15: 109-112.
CrossRef  |  PubMed  |  Direct Link  |  

Allen, K.J., L.C. Gurrin, C.C. Constantine, N.J. Osborne and M.B. Delatycki et al., 2008. Iron-overload-related disease in HFE hereditary hemochromatosis. New Engl. J. Med., 358: 221-230.
CrossRef  |  

Andrews, N.C., 1999. Disorders of iron metabolism. N. Engl. J. Med., 341: 1986-1995.
Direct Link  |  

Angelopoulos, N.G., A. Goula, G. Rombopoulos, V. Kaltzidou, E. Katounda, D. Kaltsas and G. Tolis, 2006. Hypoparathyroidism in transfusion-dependent patients with β-thalassemia. J. Bone Miner. Metab., 24: 138-145.
CrossRef  |  

Becker, M.A., H.R. Schumacher Jr., R.L. Wortmann, P.A. MacDonald and D. Eustace et al., 2005. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N. Engl. J. Med., 353: 2450-2461.
CrossRef  |  PubMed  |  Direct Link  |  

Borgna-Pignatti, C., S. Rugolotto, P. De Stefano, H. Zhao and M.D. Cappellini et al., 2004. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica, 89: 1187-1193.
PubMed  |  Direct Link  |  

Brittenham, G.M., 1992. Development of Iron-chelating agents for clinical use. Blood, 80: 569-574.
Direct Link  |  

Brittenham, G.M., P.M. Griffith, A.W. Nienhuis, C.E. McLaren and N.S. Young et al., 1994. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N. Engl. J. Med., 331: 567-573.
Direct Link  |  

Cetin, T., C. Oktenli, T. Ozgurtas, M. Yenicesu and S.Y. Sanisoglu et al., 2003. Renal tubular dysfunction in β-thalassemia minor. Am. J. Kidney Dis., 42: 1164-1168.
CrossRef  |  

Chizynski, K. and M. Rozycka, 2005. Hyperuricemia. Pol. Merkur. Lekarski, 19: 693-696.

Franchini, M., 2006. Hereditary iron overload: Update on pathophysiology, diagnosis and treatment. Am. J. Hematol., 81: 202-209.
CrossRef  |  

Jensen, P.D., 2004. Evaluation of iron overload. Br. J. Haematol., 124: 697-711.
CrossRef  |  

Kassab-Chekir, A., S. Laradi, S. Ferchichi, A.H. Khelil and M. Feki et al., 2003. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clinica Chimica Acta, 338: 79-86.
CrossRef  |  PubMed  |  Direct Link  |  

Kassab-Chekir, A., S. Laradi, S. Ferchichi, A.H. Khelil and M. Feki et al., 2003. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clinica Chimica Acta, 338: 79-86.
CrossRef  |  PubMed  |  Direct Link  |  

Low, L.C.K., 2005. Growth of children with β-thalassemia major. Indian J. Pediatr., 72: 159-164.
CrossRef  |  

Melody, J., J. Ellis and R. Alan, 2004. Complications of β-thalassemia major in North America. Blood, 104: 34-39.
CrossRef  |  

Modell, B., M. Khan, M. Darlison, A. King and M. Layton et al., 2001. A national register for surveillance of inherited disorders: β Thalassaemia in the United Kingdom. Bull. World Health Organ., 79: 1006-1013.
Direct Link  |  

Nakagawa, T., H. Hu, S. Zharikov, K.R. Tuttle and R.A. Short et al., 2006. A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal Physiol., 290: F625-F631.
CrossRef  |  PubMed  |  Direct Link  |  

Nathan, D.G. and R.B. Gunn, 1966. Thalassemia, the consequences of unbalanced hemoglobin synthesis. Am. J. Med., 41: 815-815.

Oktenli, C. and F. Bulucu, 2002. Renal tubular dysfunction in a patient with Β-thalassemia minor. Nephron, 92: 222-223.

Olivieri, N.F., 1999. The β-thalassemias. N. Engl. J. Med., 341: 99-109.
PubMed  |  

Perrone, R.D., N.E. Madias and A.S. Levey, 1992. Serum creatinine as an index of renal function: New insights into old concepts. Clin. Chem., 38: 1933-1953.
PubMed  |  Direct Link  |  

Prasannan, L., J.T. Flynn and J.E. Levine, 2003. Acute renal failure following desferrioxamine overdose. Pediatr. Nephrol., 18: 283-285.

Rund, D. and E. Rachmilewitz, 2005. Beta-thalassemia. N Engl. J. Med., 353: 1135-1146.

Sumboonnanonda, A., P. Malasit, V.S. Tanphaichitr, S. Ong-ajyooth, S. Petrarat and A. Vongjirad, 2003. Renal tubular dysfunction in α-thalassemia. Pediatric Nephrol., 18: 257-260.
CrossRef  |  PubMed  |  

Wikramasinghe, S.N., M. Hughes, S. Fucharoen and P. Wasi, 1984. The fate of excess β globin chains with in erythropoietic cells in a-thalassemia 2-trait, a-thalassemia 1 trait, haemoglobin H disease and haemoglobin QH disease: An electron microscope study. Br. J. Haematol., 56: 473-482.

Wilairat, P., A. Kittikalayawong and S. Chaicharoen, 1992. The thalassemic red cell membrane. Southeast Asian J. Trop. Med. Public Health, 2: 74-78.